Bombesin Uses, Dosage, Side Effects and more
Bombesin is under investigation in clinical trial NCT01205321 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers).
| Trade Name | Bombesin |
| Generic | Bombesin |
| Type | |
| Formula | C71H110N24O18S |
| Weight | Average: 1619.87 Monoisotopic: 1618.815063972 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
